These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298 [TBL] [Abstract][Full Text] [Related]
7. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic options for laryngeal cancer. Vokes EE; Stenson KM N Engl J Med; 2003 Nov; 349(22):2087-9. PubMed ID: 14645634 [No Abstract] [Full Text] [Related]
9. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415 [TBL] [Abstract][Full Text] [Related]
10. Treatment of laryngeal cancer: the permanent challenge. Lefebvre JL; Coche-Dequéant B; Degardin M; Kara A; Mallet Y; Ton Van J Expert Rev Anticancer Ther; 2004 Oct; 4(5):913-20. PubMed ID: 15485324 [TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma]. Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756 [TBL] [Abstract][Full Text] [Related]
15. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766 [TBL] [Abstract][Full Text] [Related]
16. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)]. Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811 [TBL] [Abstract][Full Text] [Related]
17. Searching for less toxic larynx preservation: a need for common definitions and metrics. Forastiere AA; Trotti AM J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460 [No Abstract] [Full Text] [Related]
18. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect? Pfister DG; Ridge JA J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409 [No Abstract] [Full Text] [Related]
19. Organ preservation surgery for laryngeal cancer. Tufano RP; Stafford EM Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956 [TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]